We speculated that subtype C3 ER+ BC patients may have an unfavorable prognosis, as the presence of pDCs has been reported to be associated with poor prognosis (under the premise that these cells are unstimulated; Schuster et al., 2019). This evidence concerns the gene ESR1 and breast cancer.